Henoch-Schönlein purpura risk factors

Jump to navigation Jump to search

Henoch-Schönlein purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Henoch-Schönlein purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Henoch-Schönlein purpura risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Henoch-Schönlein purpura risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Henoch-Schönlein purpura risk factors

CDC on Henoch-Schönlein purpura risk factors

Henoch-Schönlein purpura risk factors in the news

Blogs on Henoch-Schönlein purpura risk factors

Directions to Hospitals Treating Henoch-Schönlein purpura

Risk calculators and risk factors for Henoch-Schönlein purpura risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Henoch-Schönlein purpura (HSP) is associated with following risk factors it's most common in children of 2 to 6 years, involves young boys more than girls, Asian and white race, spring, fall and winter months, Group A streptococci, Mycoplasma, Epstein-Barr virus infections, and environmental exposure of allergens, organophosphates, cold temperature.

Risk Factors

The risk factors of the Henoch-Schönlein purpura are as follows:[1][2][3][4][5]

References

  1. Park SJ, Suh JS, Lee JH, Lee JW, Kim SH, Han KH, Shin JI (December 2013). "Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis". Expert Rev Clin Immunol. 9 (12): 1223–38. doi:10.1586/1744666X.2013.850028. PMID 24215411.
  2. Saulsbury FT (January 2001). "Henoch-Schönlein purpura". Curr Opin Rheumatol. 13 (1): 35–40. PMID 11148713.
  3. Bucher B, Fiore E, Bernasconi M, Blumberg D, Garzoni L, Rizzi M, Bianchetti MG (May 2008). "[Childhood Henoch-Schönlein syndrome--common and uncommon features, complications, Finkelstein-Seidlmayer variant and management]". Ther Umsch (in German). 65 (5): 269–77. doi:10.1024/0040-5930.65.5.269. PMID 18622931.
  4. Nunnelee JD (March 2000). "Henoch-Schönlein purpura: a review of the literature". Clin Excell Nurse Pract. 4 (2): 72–5. PMID 11075047.
  5. Patrignelli R, Sheikh SH, Shaw-Stiffel TA (May 1995). "Henoch-Schönlein purpura. A multisystem disease also seen in adults". Postgrad Med. 97 (5): 123–4, 127, 131–4. PMID 7753737.


Template:WH Template:WS